The nanotechnology-based therapies have demonstrated great promise in revolutionizing cancer medicine by improving efficacy while reducing the adverse effects. Despite recent progress in newer nanotechnologies, the bench-tobedside translation of nanotechnology-based therapies is very poor. This theme issue of AAPS PharmSciTech provides a broad overview of the critical steps and approaches in the development of various nanosystems for the delivery of small-molecule drugs and nucleic acids for cancer therapy.
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This theme issue of AAPS PharmSciTech offers nine review articles. Babu (12) . Coated by thermosensitive copolymer poly-(NIPAM-stat-AAm)-b-PEI, Dani et al. explored iron oxide nanoparticles for the delivery of doxorubicin and found that the release and cytotoxicity of doxorubicin could be triggered by raising the temperature (13). Grover et al. studied docetaxelloaded glutathione-coated PEG-PLGA nanoparticles, which exerted significantly more potent cytotoxicity than free docetaxel against glioma cells (14) .
The various aspects of formulation development, characterization, biocompatibility, preclinical evaluation, and clinical application of nanomedicine are all essential to the realization of the full potential of nanotechnology-based therapies. Concerted efforts among scientists in different disciplines are required to bridge the information between the basic and clinical research to expedite the translational application of nano delivery systems for effective cancer therapy.
